Xolair: First head-to-head study cements Roche's Xolair as food allergy leader

Roche's asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children with one or more food allergies.The post First head-to-head study cements Roche's Xolair as food allergy leader appeared first on PharmaLive.